Bausch Health Companies Inc. Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31)
Bausch Health Companies Inc. (BHC) reported Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) of -$24.54 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease · last filed 2012-08-03
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-06-30 was -$197.44M, a 402.31% decline year-over-year.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $172.91M, a 45.57% increase year-over-year.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$18.37M, a 135.40% decline year-over-year.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was -$469.20M, a 9655.97% decline year-over-year.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2011 was -$303.47M, a 649.15% decline from fiscal 2010.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2010 was $55.26M, a 208.64% increase from fiscal 2009.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2009 was $17.91M.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2008 was -$36.91M.
| Period end | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$197.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$24.54M 10-Q · filed 2012-08-03 | -$42.91M derived: sum of 3 quarters · filed 2012-08-03 | -$512.10M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $172.91M 10-Q · filed 2012-05-04 | $154.54M derived: sum of 2 quarters · filed 2012-05-04 | -$314.66M derived: sum of 3 quarters · filed 2012-05-04 | -$249.35M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | -$18.37M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$487.56M derived: sum of 2 quarters · filed 2012-02-29 | -$422.25M derived: sum of 3 quarters · filed 2012-02-29 | -$303.47M 10-K · filed 2012-02-29 |
| 2011-09-30 | -$469.20M 10-Q · filed 2011-11-04 | -$403.88M derived: sum of 2 quarters · filed 2011-11-04 | -$285.11M 10-Q · filed 2011-11-04 | -$233.22M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $65.31M 10-Q · filed 2011-08-08 | $184.09M 10-Q · filed 2012-08-03 | $235.98M derived: sum of 3 quarters · filed 2012-05-04 | $240.89M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | $118.78M 10-Q · filed 2012-05-04 | $170.67M derived: sum of 2 quarters · filed 2012-05-04 | $175.58M derived: sum of 3 quarters · filed 2012-05-04 | $169.91M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | $51.89M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $56.80M derived: sum of 2 quarters · filed 2012-02-29 | $51.13M derived: sum of 3 quarters · filed 2012-02-29 | $55.26M 10-K · filed 2012-02-29 |
| 2010-09-30 | $4.91M 10-Q · filed 2011-11-04 | -$761.00K derived: sum of 2 quarters · filed 2011-11-04 | $3.37M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | -$5.67M 10-Q · filed 2011-08-08 | -$1.54M 10-Q · filed 2011-08-08 | ||
| 2009-12-31 | $17.91M 10-K · filed 2012-02-29 | |||
| 2008-12-31 | -$36.91M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |